German pharma giant Merck KGaA has appointed two young executives in leading roles: Isabel De Paoli as Head of Corporate Strategy and Friederike Rotsch as Head of Corporate Auditing.
Both executives will report to Karl-Ludwig Kley, Chairman of Merck’s Executive Board.
Isabel De Paoli (37) worked as a consultant at the Boston Consulting Group and a manager at private equity firm Permira Beteiligungsberatung before joining Merck’s Chemicals Business Development in 2006. She moved to the Merck Serono division in 2009, and then became Head of Global Strategic Planning Oncology.
Dr. Friederike Rotsch (39) worked as a lawyer at Hengeler Mueller before joining Merck’s Legal Department in 2005, with responsibility for corporate governance. Her role involved supporting the company’s acquisition of Serono and the divestment of its generics business. In 2007 she became Head of Corporate Legal Services at Merck.
“I am pleased that we are filling leadership positions within Corporate Auditing and Corporate Strategy, two important functions, with experienced managers from within our ranks,” said Karl-Ludwig Kley. “Both Group functions will be playing a key role in the further development of Merck.”
Based in Darmstadt, Germany, Merck KGaA trades in the UK as Merck.
Share this article: